These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2535300)

  • 41. Enoximone. A review of its pharmacological properties and therapeutic potential.
    Vernon MW; Heel RC; Brogden RN
    Drugs; 1991 Dec; 42(6):997-1017. PubMed ID: 1724645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enoximone versus dopamine in patients being weaned from cardiopulmonary bypass.
    Birnbaum DE; Preuner JG; Gieseke R; Trenk D; Jaehnchen E
    Cardiology; 1990; 77 Suppl 3():34-41; discussion 62-7. PubMed ID: 2148278
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enoximone in intensive care. Proceedings of a symposium. Brussels, Belgium, 21st March 1988.
    Br J Clin Pract Suppl; 1988 Dec; 64():1-87. PubMed ID: 2978495
    [No Abstract]   [Full Text] [Related]  

  • 44. Augmentation of diastolic function with phosphodiesterase inhibition in congestive heart failure.
    Binkley PF; Shaffer PB; Ryan JM; Leier CV
    J Lab Clin Med; 1989 Sep; 114(3):266-71. PubMed ID: 2527935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Enoximone].
    Ventura G
    Medicina (Firenze); 1990; 10(2):191-3. PubMed ID: 2148796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Placebo-controlled trial of oral enoximone in end-stage congestive heart failure refractory to optimal treatment.
    Dubourg O; Delorme G; Hardy A; Beauchet A; Tarral A; Bourdarias JP
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S33-42; discussion S43. PubMed ID: 2145237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enoximone in newborns with refractory postoperative low-output states (LOS).
    Hausdorf G; Friedel N; Berdjis F; Dieterich HA; Fell JJ; Dressler HT; Werneyer A; Hetzer R; Lange PE
    Eur J Cardiothorac Surg; 1992; 6(6):311-7. PubMed ID: 1535503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enoximone in chronic heart failure.
    Swan HJ
    Circulation; 1990 Sep; 82(3):1049-50. PubMed ID: 2144215
    [No Abstract]   [Full Text] [Related]  

  • 49. [Enoximone: hemodynamic effect in patients with cardiac insufficiency].
    de Langenhagen B; Bouchoucha H; Scholl JM; Hennetier G; Benacerraf A; Achard F; Bock F
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of intravenous pimobendan (UDCG 115 BS) on hemodynamics and left ventricular volumes in idiopathic dilative cardiomyopathy.
    Permanetter B; Sebening H; Hartmann F; Baumann G; Lutilsky L
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):803-9. PubMed ID: 2481765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparison of new cardiac agents using differential therapeutic criteria].
    Redmann K; Lunkenheimer PP; Rettig G; Isringhaus H; Flameng W; Demeyere R
    Z Kardiol; 1991; 80 Suppl 4():7-14. PubMed ID: 1833902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Haemodynamic effects of R 80122 immediately after cardiopulmonary bypass; preliminary results.
    Herregods L; Rolly G; Van Belleghem Y; Van Nooten G
    Anaesthesia; 1994 Aug; 49(8):719-22. PubMed ID: 7943708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Continuous enoximone infusion in patients with severe heart failure in dilated cardiomyopathy, hemodynamic, neurohumoral, chemical laboratory and clinical results].
    Neuzner J; Mitrovic V; Pitschner HF; Lissmann H; Schlepper M
    Z Kardiol; 1991 Jun; 80(6):397-403. PubMed ID: 1681628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Long-term therapy of chronic cardiac insufficiency using enoximone].
    Treese N; Erbel R; Rhein S; Diefenbach C; Alken RG; Mohr-Kahaly S; Meyer J
    Dtsch Med Wochenschr; 1987 Jul; 112(30):1163-9. PubMed ID: 2956080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of haemodynamic efficacy of enoximone and dobutamine in coronary surgery patients.
    Boldt J; Dieterich HA; Hempelmann G
    Br J Clin Pract Suppl; 1988 Dec; 64():41-5. PubMed ID: 2978499
    [No Abstract]   [Full Text] [Related]  

  • 56. [Use of a new inotropic agent, enoximone, in heart surgery].
    Gomar C; Fita G; Pomar JL; Valero R; Mulet J; Nalda MA
    Rev Esp Anestesiol Reanim; 1991; 38(2):121-6. PubMed ID: 1678896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of enoximone and piroximone in patients after mitral valve operation: a prospective and controlled clinical study.
    Hausen B; Heublein B; Vogelpohl J; von der Leyen H; Haverich A
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):299-307. PubMed ID: 1378106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Haemodynamic changes produced by inhalation anaesthetics in the presence of phosphodiesterase inhibition.
    Molter G; Larsen R; Peters U; Bauch U; Sefrin R
    Br J Anaesth; 1993 Apr; 70(4):428-33. PubMed ID: 8499203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Central and regional hemodynamic effects of oral enoximone in congestive heart failure: a double-blind, placebo-controlled study.
    Leier CV; Lima JJ; Meiler SE; Unverferth DV
    Am Heart J; 1988 May; 115(5):1051-9. PubMed ID: 2966546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA
    Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.